Canadian application, no grantCanada
Activatable recombinant neurotoxins
CA 2380457 A1 · Owner: Allergan Sales, Llc · Inventors: Dolly, J. Oliver; Chan, Kuo Chion; Li, Yan
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions comprising activable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 25, 2000
GrantedNo grant recorded
Term endedAugust 25, 2020
Patent numberCA 2380457 A1
Classification (IPC)C12N15/62 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.